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Abstract
Candida albicans is a diploid fungus that undergoes a morphological transition between budding yeast, hyphal, and pseudohyphal forms. The morphological transition is strongly correlated with virulence and is regulated in part by quorum sensing.
Candida albicans produces and secretes farnesol that regulates the yeast to mycelia morphological transition. Mutants that fail to synthesize or respond to farnesol could be locked in the filamentous mode. To test this hypothesis, a collection of
C. albicans mutants were isolated that have altered colony morphologies indicative
of the presence of hyphal cells under environmental conditions where C. albicans
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normally grows only as yeasts. All mutants were characterized for their ability to
respond to farnesol. Of these, 95.9% fully or partially reverted to wildtype morphology on yeast malt (YM) agar plates supplemented with farnesol. All mutants
that respond to farnesol regained their hyphal morphology when restreaked on
YM plates without farnesol. The observation that farnesol remedial mutants are so
common (95.9%) relative to mutants that fail to respond to farnesol (4.1%) suggests that farnesol activates and (or) induces a pathway that can override many of
the morphogenesis defects in these mutants. Additionally, 9 mutants chosen at random were screened for farnesol production. Two mutants failed to produce detectable levels of farnesol.
Keywords: farnesol-remedial mutants, farnesol-sensing mutants, farnesol-synthesis mutants, quorum sensing, Candida albicans, morphological transition.
Résumé
Candida albicans est un champignon diploïde qui subit une transition morphologique
entre les levures en herbe, les hyphes et les formes pseudohyphales. La transition
morphologique est fortement corrélée à la virulence et est régulée en partie par la
détection du quorum. Candida albicans produit et sécrète du farnésol qui régule la
transition morphologique levure-mycélium. Les mutants qui ne parviennent pas
à synthétiser ou à répondre au farnésol pourraient être verrouillés en mode filamenteux. Pour tester cette hypothèse, une collection de mutants de C. albicans a
été isolée qui ont modifié les morphologies des colonies, indiquant la présence de
cellules hyphales dans des conditions environnementales où C. albicans ne pousse
normalement que sous forme de levures. Tous les mutants ont été caractérisés pour
leur capacité à répondre au farnésol. Parmi ceux-ci, 95,9% sont entièrement ou partiellement revenus à la morphologie de type sauvage sur des plaques de gélose au
levure de malt (YM) complétées par du farnésol. Tous les mutants qui répondent
au farnésol ont retrouvé leur morphologie hyphale lorsqu’ils ont été recréés sur
des plaques YM sans farnésol. L’observation selon laquelle les mutants curatifs du
farnésol sont si communs (95,9%) par rapport aux mutants qui ne répondent pas
au farnésol (4,1%) suggère que le farnésol s’active et (ou) induit une voie qui peut
supplanter bon nombre des défauts de morphogenèse de ces mutants. De plus, 9
mutants choisis au hasard ont été testés pour la production de farnésol. Deux mutants n’ont pas réussi à produire des niveaux détectables de farnésol.
Mots-clés: mutants réparateurs du farnésol, mutants sensibles au farnésol, mutants de synthèse du farnésol, détection du quorum, Candida albicans, transition
morphologique.

Introduction
The dimorphic fungus Candida albicans is the causative agent of vaginal yeast infections, oral thrush, and a series of other fungal maladies. Normally, C. albicans is a member of the intestinal tract flora.
It becomes a pathogen when conditions permit it to adhere, colonize,
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and invade epithelial tissues. Premature infants, surgical patients, and
cancer patients receiving immunosuppressive chemotherapy are especially at risk for developing candidiasis. This is a serious disease,
as 30%–38% of the patients with candidiasis die (Viudes et al. 2002;
Gudlaugsson et al. 2003).
Candida albicans undergoes a morphological transition between
a budding yeast form and the hyphal and pseudohyphal forms. The
morphological transition is strongly correlated with virulence because
yeast- and mycelia-only mutants are non-infective in a mouse model
(Lo et al. 1997; Bendel et al. 2003). The mycelial and yeast forms are
probably important for colonization and spread, respectively. This
morphological transition is regulated by many environmental and
chemical signals including temperature and quorum sensing (Hornby
et al. 2001). With regard to temperature, C. albicans generally grows
as yeasts at ≤30 °C and as filaments at 37 °C. With regards to quorum sensing, C. albicans produces and secretes an extracellular molecule, farnesol, which regulates the morphological transition (Hornby
et al. 2001). During growth at 37 °C, farnesol accumulates, hyphal development is inhibited, and the cells grow instead as budding yeasts.
Exogenous farnesol also blocks the yeast to filamentous conversion
in response to most, if not all, environmental and chemical inducers
(Mosel et al. 2005). Because the morphological transition is critical
for pathogenicity, it is important to understand how it is regulated by
farnesol. In particular, we ultimately want to know how many farnesol-binding targets exist, and how farnesol binding leads to an altered
cell morphology.
Mutants that fail to synthesize or respond to farnesol should be
unable to block the yeast to mycelia conversion and thus would be
more likely to grow in the filamentous mode. They may even lose
the ability to grow in the yeast form. To test this hypothesis, we isolated a collection of C. albicans mutants that had a hyphal or pseudohyphal morphology under environmental conditions (28 °C) where
C. albicans normally grows as yeasts and characterized the ability of
these mutants to respond to farnesol. We found that farnesol-responsive mutants existed and were common. A subset of the mutants was
also tested for their ability to synthesize farnesol. Two mutants did
not synthesize detectable amounts of farnesol. The analysis of these
mutants is an important first step in understanding the role farnesol
plays in regulation of the C. albicans morphological transition.
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Materials and methods
Strains and media
Candida albicans A72 (kindly provided by Patrick A. Sullivan, University of Otago, New Zealand) was originally isolated from a patient
by Dr. Antonio Cassone (Rome, Italy). It does not have any auxotrophic markers and it is available from the American Type Culture Collection (Rockville, Md.) as strain MYA2430. Candida albicans CAI-4
(ura3::imm434/ura3::imm434; Fonzi and Irwin 1993) was obtained
from Gerald Fink at the Whitehead Institute for Biomedical Research
(Cambridge, Mass.). CAI-4 is derived from SC5314, a clinical isolate,
by gene replacement using homologous recombination to replace both
copies of its URA3 gene (Fonzi and Irwin 1993). CAI-4 also has a deletion of the 3′ half of IRO1 and, thus, is partially defective in iron uptake and utilization (Garcia et al. 2001). A72 and CAI-4 produce spontaneous odd colonies at a frequency of about 1 in 10,000 (0.01%).
However, none of these spontaneous odd colonies were stable; they all
changed colony morphology within 3–4 transfers. Thus, stability beyond 3–4 transfers was the criterion we used to select stable altered
colony morphologies. These cells are either mutants or they have an
exceptionally stable colony-type switch. For simplicity in this paper,
we use the term “mutants” to describe these cells. A72 and CAI-4 were
used in both mutagenesis protocols described below.
Strains were maintained on yeast malt (YM; Difco Laboratories,
Sparks, Md.; Tucker, Ga.; Barret et al. 1990) or YEPD (1% w/v yeast
extract, 2% w/v bacto peptone, 2% w/v glucose) agar stored at 4 °C.
Other media used were yeast nitrogen base (YNB; Difco) supplemented
with 2.5 mmol/L N-acetylglucosamine, a defined glucose–phosphate–
proline medium with 2.5 mmol/L N-acetylglucosamine (mGPP), and a
modified glucose–salts–biotin (mGSB) medium. The mGPP (Hornby et
al. 2001) contained the following on a per liter basis: 20 g glucose, 1.15
g l-proline, 0.55 g N–acetylglucosamine, 4 g KH2PO4, 3.2 g Na2 HPO4,
0.5 g MgSO4·7H2O, 1 mg CuSO4·5H2O, 1 mg ZnSO4·7H2O, 1 mg MnCl2, 1
mg FeSO4, 20 μg biotin, 200 μg pyridoxine·HCl, 200 mg thiamine·HCl
(pH 6.5). The glucose (20% w/v) and l-proline (100 mmol/L) were
autoclaved separately and added aseptically, as were the filter-sterilized vitamins (1000-fold stock prepared in 20% v/v ethanol). The
mGSB (Hornby et al. 2001) medium contained the following on a per
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liter basis: 1 g (NH4)2SO4, 2 g KH2PO4, 50 mg MgSO4·7H2O, 50 mg
CaCl2·2H2O, and 1 g peptone. After autoclaving, 30 mL of 50% w/v
glucose and 0.4 mL of the mGPP vitamin stock were added aseptically.
Mutagenesis and isolation of mutants
Candida albicans cells with a stable altered colony morphology were
selected from cultures treated with 2 mutagenesis protocols. The first
protocol consisted of treatment with ethylmethane sulfonate (EMS),
to stimulate a high number of transitions at GC sites (Kohalmi and
Kunz 1988), followed by ultraviolet (UV) irradiation. Candida albicans is diploid and UV irradiation was used to stimulate mitotic recombination, thus making recovery of recessive mutations possible
(Kakar et al. 1983). The second protocol consisted of treatment with
EMS followed by nitrous acid. Nitrous acid stimulates transitions at
and GC sites. In both mutagenesis schemes, A72 and CAI-4 were mutagenized to 50% viability.
Candida albicans A72 cells from a 5- to 7-day-old YM agar plate
were transferred to 50 mL mGSB medium and grown at 30 °C for 30
h to stationary phase with shaking at 200 r/min. The cells were recovered by centrifugation for 10 min at 4350g (6000 rpm in a Beckman JA-20 rotor) and washed 3 times with 10 mL of 0.05 mol/L potassium phosphate buffer (pH 6.5). The washed cells were resuspended
in 10 mL of this buffer. A “time 0” cell titer was determined by removing a 0.1 mL sample that was diluted and plated onto YM agar to give
150–200 colonies per plate. Two hundred fifty microliters of EMS was
added to the remaining 9.9 mL cell suspension. This mixture was incubated for 40 min at room temperature with gentle mixing every 5
min. EMS was then neutralized by adding 10 mL of 6% w/v sodium
thiosulfate and incubating for 20 min at room temperature. The cells
were washed once with 10 mL of 6% w/v sodium thiosulfate and twice
with 10 mL of 0.05 mol/L potassium phosphate buffer (pH 6.5). The
cells were resuspended in 10 mL of 0.05 mol/L potassium phosphate
buffer (pH 6.5), diluted (by a factor of 10–4 and 10–5), and plated on
YM agar. The plates were subjected to 50 J of ultraviolet light C (UVC) (2.5 J/s for 20 s) and incubated at 30 °C until colonies were visible.
Nitrous acid mutagenesis was basically identical to that used by Kakar et al. (1983). Cells were grown and collected via centrifugation as
described for EMS mutagenesis. However, the cells were washed and
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resuspended in 10 mL of 0.1 mol/L sodium acetate buffer (pH 4.5) instead of in the phosphate buffer used for EMS. A time 0 titer was obtained in an identical fashion as for EMS mutagenesis. The remaining
9.9 mL of cell suspension was centrifuged and resuspended in 9.9 mL
of filter-sterilized 0.1 mol/L sodium acetate buffer (pH 4.5) containing 0.06 mol/L sodium nitrite and incubated at room temperature. After 15–25 min, mutagenesis was stopped by the addition of 5 mL of 0.5
mol/L potassium phosphate buffer (pH 7.5). Mutated cells were diluted
using 0.05 mol/L phosphate buffer (pH 7.5) to obtain 150–200 colonies when 0.1 mL was spread on a YM agar plate. The YM agar plates
were incubated at 30 °C until colonies were visible. The normal colony
morphology on YM agar plates at 30 °C is a smooth, circular colony.
The mutagenized colonies were examined for odd colony morphologies. Cells from odd morphology colonies were transferred to
both fresh YM agar and mGPP agar plates. The mGPP plates selected
against auxotrophs. Isolates that formed colonies of similar size to the
wild-type, grew in mGPP, and maintained their odd colony morphology for at least 4 transfers on YM agar plates were saved for future
study. The protocol for C. albicans CAI-4 was the same as for A72 except that all media were supplemented with 40 mg/L uridine.
Phase-contrast microscopy
Cells from the isolate of interest were inoculated onto a YM agar plate
and incubated at 28 °C for 5 d for A72 mutants or 7 d for CAI-4 mutants. A longer incubation period was required for CAI-4 to compensate for its slower growth rate. For smooth colonies, all visible cellular material from a 2.5 mm colony or a 2.5 × 2.5 mm section from a
line inoculation was suspended in 1.0 mL of sterile 0.05 mol/L potassium phosphate buffer (pH 6.5) and vortexed for 1 min to separate the
cells. If the isolate of interest came from a colony whose texture was
hard, indicating filaments only, or rubbery, indicating a high percentage of filaments, a 5-times larger area of cells was removed and homogenized using a sterile Pyrex hand homogenizer with 5 mL of phosphate buffer. Homogenization was necessary because in these cases
vortexing did not result in individual cells. Cells were observed using a 40× phase-contrast lens on an Olympus BH2-RFCA microscope
equipped with an Olympus C-2000 zoom digital camera (Olympus
America Inc., Melville, N.Y.).
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Farnesol-response assays
YM agar plates were supplemented with 10, 50, or 100 μmol/L mixed
isomer farnesol (Sigma, St. Louis, Mo.). A frozen stock of 100 mmol/L
farnesol in ethanol was brought to room temperature and aliquoted
into empty petri dishes. The liquid medium (55 °C) was added and
the plates were swirled to mix. Line inoculations were used and plates
were incubated at 28 °C for 5 or 7 d for A72 and CAI-4, respectively.
For each isolate, the morphology of the streak was compared with a
control plate with no added farnesol. Isolates were examined for any
reduction in length or density of hairs and (or) reduction in wrinkles.
Analysis of farnesol-production assays by gas chromatography
and mass spectrometry (GC/MS)
Cells were grown in mGPP at 30 °C. Extracellular farnesol from cellfree supernatants was analyzed by GC/MS as described previously
(Hornby et al. 2001; Hornby and Nickerson 2004).

Results
Isolation of C. albicans heritable colony morphological variants
Candida albicans cells with a stable altered colony morphology were
isolated following mutagenesis of 2 parent strains, A72 and CAI-4.
These parental strains were chosen because they are well-characterized farnesol-producing and farnesol-responsive strains that have been
previously used in in vitro studies (Hornby et al. 2001, 2003; Hornby
and Nickerson 2004; Shchepin et al. 2003).
EMS–UV mutagenesis
For our first collection, cells were treated with EMS, followed by UV
irradiation. One hundred thirty-four (0.1%) of the ca. 90 500 A72 survivors and 606 (0.6%) of the ca. 95 000 CAI-4 survivors had an odd
colony morphology that was maintained following at least 4 transfers
on YM or YEPD agar at 30 °C (Table 1). Under these conditions, unmutagenized A72 and CAI-4 cells form smooth colonies with yeast cells
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Table 1. Categories of colony morphology mutants obtained from C. albicans A72 and CAI-4.
A72 		
Category
Hairy
Stippled
Hairy stippled
Wrinkled
Hairy wrinkled
Mountain-like
Shaggy dog
Total

CAI-4

EMS–UV

EMS – nitrous acid

EMS–UV

EMS – nitrous acid

129
1
1
0
2
0
1
134

158
6
25
5
23
0
0
217

167
0
0
1
424
14
0
606

49
0
12
3
90
0
0
154

Note: Candida albicans cells were mutagenized by either EMS followed by UV irradiation or
by EMS followed by nitrous acid application. Colonies with a stable altered morphology were
selected on YM agar at 30 °C.

only (Figs. 1 and 2). The mutants fell into 7 distinct categories based
on colony type: hairy, stippled, hairy stippled, wrinkled, hairy wrinkled, mountain-like, and shaggy dog. Representative mutants of each
type are shown in Fig. 1. The majority of A72 mutants (96.3%) were in

Fig. 1. Representative examples of colony morphologies of parental strains and mutants obtained in the screen. Candida albicans cells were plated on YM agar and incubated for 5 d at 28 °C. Representative colony morphologies for (A) parental strain
A72, (B) parental strain CAI-4, and mutants (C) shaggy dog, (D) hairy, (E) stippled,
(F) wrinkled, (G) hairy stippled, (H) hairy wrinkled, and (I) mountain-like. The
shaggy dog and mountain-like morphologies were unique for mutants of A72 and
CAI-4, respectively. Mutants with the other mutant colony morphology types were
recovered from both A72 and CAI-4.
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Fig. 2. Examples of cell morphologies of parental strains and mutants obtained in
the screen. (A) Parental strain A72 (average cell size 4 μm × 4.8 μm), (B) a hairy
mutant (average mycelia width 2.5 μm) and (C) a shaggy dog mutant (average mycelia width 3.5 μm).
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the hairy category, whereas the majority of CAI-4 mutants (70%) were
in the hairy wrinkled category. The second-highest number of CAI-4
mutants (26.6%) was in the hairy category (Table 1). Each of these
mutants was stable for ≥4 transfers and, for each mutant, a survey
of a minimum of 1000 colonies showed uniform colony morphology.
A clear relationship between C. albicans colony morphology and cell
morphology has been well established (Radford et al. 1994). To confirm
that colony morphology correlated with individual cell morphology,
we examined a subset of the mutants grown at 28 °C by microscopy.
This subset consisted of all 740 of the mutants generated by EMS–UV.
Unmutagenized A72 and CAI-4 strains grew as yeasts only. Of the 740
EMS–UV mutants described in Table 1, 1 A72 mutant in the shaggy dog
category and 14 CAI-4 mutants in the mountain-like category grew as
filaments only. The other 725 EMS/UV mutants all grew as a mixture
of yeasts and filaments. Representative micrographs of the A72 parent
strain and mutants are shown in Fig. 2. The variety of altered colony
types is similar to those observed for phenotypic colony-type switching by Radford et al. (1994) and Perez-Martin et al. (1999).
EMS – nitrous acid mutagenesis
Low doses of UV irradiation (>90% survival) cause an increase in
the frequency of colony-type switching in C. albicans (Slutsky et al.
1985; Soll 1997). To reduce the possibility that some of the mutants
we recovered in our screen were not actually mutants, but might instead have resulted from exceptionally stable colony-type switching,
we mutagenized A72 and CAI-4 with EMS, followed by nitrous acid.
Currently, there is no reference for either EMS or nitrous acid inducing phenotypic switching. In this screen, we found that 217 (0.3%) of
the ca. 80 420 A72 survivors and 154 (0.2%) of ca. 75 000 CAI-4 survivors maintained odd colony morphology following ≥4 transfers on
YM agar (Table 1). These mutants fell into 6 distinct categories based
on colony morphology: hairy, stippled, hairy stippled, wrinkled, hairy
wrinkled, and mountain-like. No shaggy dog mutants were isolated.
Again, the majority of A72 mutants (72.8%) were in the hairy category, whereas the majority of CAI-4 mutants (58.4%) were in the
hairy wrinkled category with the second highest number (31.8%) in
the hairy category. Thus, similar results were obtained when EMS was
used in combination with either UV or nitrous acid.
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Table 2. Farnesol reversal of “mutant” colony phenotype.
Category

A72

CAI-4

Complete response
Partial response
No response
Total

191
135
25
351

292
448
20
760

Note: The effect of exogenous farnesol was measured by examining colony phenotype on YM
agar containing 0 and 100 μmol/L farnesol at 28 °C. Mutants were categorized as “complete
response” if they reverted to a wild-type phenotype (smooth and entire colonies) in the presence of 100 μmol/L farnesol. Mutants were categorized as “partial response” if the presence
of 100 μmol/L farnesol caused a decrease in hair length, hair density, and (or) a decrease in
wrinkling. Mutants were categorized as “no response” if farnesol caused no visible changes
in colony morphology.

Farnesol-responsive mutants
All of the A72 and CAI-4 mutants (1111) were screened for their responsiveness to farnesol. They were tested on YM medium containing 0, 10, 50, and 100 μmol/L farnesol at 28 °C. It should be noted
that for wild-type cells, 1– 2 μmol/L farnesol is sufficient to block the
yeast to mycelial conversion (Mosel et al. 2005). A very high percentage of these mutants responded to farnesol addition by changing their
colony morphology. On YM plates with farnesol, 191 (54.4%) of 351
A72 mutants and 292 (38.4%) of 760 CAI-4 mutants fully reverted to
wild-type morphology (Table 2) as judged by the formation of smooth
and entire colonies (Fig. 3). Another group of mutants partially reverted in the presence of farnesol. In this group, which included 135
(38.5%) of 351 A72 mutants and 448 (58.9%) of 760 CAI-4 mutants,
farnesol reduced the wrinkled appearance in the center of the colony
and shortened the hairs on the periphery, while simultaneously making the hairs less dense (Fig. 3; Table 2). Thus, 326 (92.9%) of the A72
mutants and 740 (97.4%) of the CAI-4 mutants responded to farnesol.
These mutants were designated “farnesol responders”. Significantly,
all farnesol responders exhibited a temporary or reversible response
to farnesol. That is, they reverted towards wild-type colony morphology on YM plus farnesol, but then regained their altered colony morphology when restreaked on YM without farnesol. Microscopic examination of the responding mutants confirmed that colony morphology
changes were accompanied by decreased filaments and an increased
percentage of budding yeasts (data not shown).
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Fig. 3. Representative examples of mutants that revert to wild type (complete response), partially revert (incomplete response), or show no change (no response)
in the presence of farnesol. Candida albicans cells were plated on YM agar containing 0, 10, 50, or 100 μmol/L farnesol and incubated for 5 d at 28 °C.

The remaining 25 (7.1%) of 351 A72 mutants and 20 (2.6%) of 760
CAI-4 mutants did not respond to farnesol (Table 2) as judged by an
unchanged colony morphology on YM plates with 100 μmol/L farnesol. These mutants were designated “farnesol non-responders”. The
non-responding mutants did not exhibit decreased filamentation (data
not shown).
Farnesol production in 9 of the C. albicans colony morphology
variants
An attractive model suggests that mutants locked into the filamentous mode either failed to synthesize farnesol or failed to respond to
farnesol. To test this hypothesis, 4 mountain-like mutants (filamentous only) and 5 hairy wrinkled mutants (yeast–filament mixtures)
were analyzed for farnesol production by GC/MS (Table 3). These mutants, chosen at random, were all derived from CAI-4. Farnesol production in the CAI-4 parent was 0.11 ± 0.02 mg/g cells. All but 2 of the
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Table 3. Extracellular farnesol produced by parent strains and selected mutants derived from
the CAI-4 parent.
Category
Strain
Colony morphology
Farnesol response
			
CAI-4
H125
H1
M3
H383
H152
H68
H253
H88
H121

Parent N/A
Mountain-like
Mountain-like
Mountain-like
Mountain-like
Hairy wrinkled
Hairy wrinkled
Hairy winkled
Hairy wrinkled
Hairy wrinkled

0.11 (±0.02)*
Complete
Partial
Partial
Complete
Complete
Complete
Complete
Complete
Complete

Farnesol concentration
(mg/g cell dry mass)
Not detectable†
0.10
0.64
0.29
0.09
0.14
0.62
0.46
Not detectable†

Note: Mountain-like and hairy wrinkled mutants were randomly selected for analysis.
* Twenty replicates were used to measure farnesol production in the CAI-4 parent strain. This
value (0.11 mg/g cell dry mass) agrees nicely with that of (0.12 mg/g cell dry mass) previously reported based on 6 determinations (Hornby and Nickerson 2004). The amount of
farnesol for the other samples is an average of duplicate samples that agree ±10%.
† No farnesol was detected in 2 independent studies (detection limit of 0.005 mg/g).

mutants produced extracellular farnesol at levels that were similar to
or greater than the CAI-4 parent. H125, a mountain-like mutant, and
H121, a hairy wrinkled mutant, did not produce detectable farnesol.

Discussion
We have characterized a collection of C. albicans mutants that are altered in their colony morphology. One thousand one hundred eleven
stable mutants with altered colony morphology were obtained and
then tested for their response to farnesol. We found that farnesol-responsive mutants existed and were common. The majority of our morphological mutants (92.9% of the A72 mutants and 97.4% of the CAI-4
mutants) responded reversibly to farnesol. These mutants represent
a novel collection of conditional morphological mutants. Presumably,
the differences in farnesol responsiveness could result from partial
loss-of-function mutations in 1 gene, mutations in several different
genes, or activation and (or) induction of a second farnesol-response
pathway that overrides the morphogenesis defect in the mutants. Because farnesol-responsive mutants are reversible and because they
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are so common relative to mutants that fail to respond to farnesol,
we think it is likely that farnesol activates and (or) induces a pathway
that can override the morphogenesis defects in many of the farnesolresponsive mutants. Candida albicans is a diploid fungus. In this regard, the significance of farnesol remedial mutants does not depend
on whether the mutants in our collection are: (i) altered in both copies of a gene, as was intended from the double mutagenesis protocols
used (Kakar et al. 1983); (ii) single-copy haplo-insufficient mutants
(Uhl et al. 2003); or (iii) exceptionally stable phenotypic switches. In
each case, the reversal of the colony morphology phenotype by farnesol should be of interest.
We expect many of the mutants in our collection to result from
haplo-insufficiency. Uhl et al. (2003) used transposon mutagenesis to
conduct a large-scale loss-of-function genetic screen for haplo-insufficient mutations that affect the switch between yeast and filamentous
growth in C. albicans. They identified mutations in 146 genes from a
library of 18 000 strains. This study was significant because they demonstrated the utility of haplo-insufficiency for identifying mutations
in genes affecting the morphogenic switch in C. albicans. We believe
that many of our mutants may also be haplo-insufficient for the following reasons: (i) as Uhl et al. (2003) demonstrated, haplo-insufficient mutations affecting morphogenesis are common; (ii) we recovered morphological mutants at frequencies of 0.1% for A72 and 0.6%
for CAI-4, values similar to the frequency of morphological mutants
in the Uhl et al. (2003) screen (0.08%); and (iii) we recovered the 7
categories of morphological mutants at similar frequencies after treatment with different combinations of mutagens (Table 1).
Some of our mutants may also result from colony-type switching.
Candida albicans can spontaneously and reversibly switch between at
least 7 general phenotypes that can be seen by changes in colony morphology, a form of phenotypic switching (Slutsky et al. 1985). Spontaneous colony variants of C. albicans 3153A occur at a frequency of 1.4
× 10–4 (0.01%). The phenotype of the colony variants is heritable, because the phenotypes persist through several clonal platings, with the
caveat that these variants themselves have a high rate of secondary
spontaneous switching. For example, colony variants of 3153A have
secondary switching frequencies of 4.9 × 10–2 (4.9%). Low doses of
UV light (>90% survival) increase phenotypic switching in C. albicans
3153A by a factor of approximately 200 (Slutsky et al. 1985). Again,
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the UV-treated 3153A colony variants have a high secondary- switching frequency (2.5 × 10–2 or 2.5%). Our screen also recovered highfrequency switchers, but we did not keep them. Instead, the mutants
described herein were selected to give a low secondary-switching frequency and were distinct from high-frequency switchers in 3 ways: (i)
many of our mutants were originally isolated in 2001 and their morphological phenotype has been maintained through greater than 10
transfers; (ii) for each mutant, a survey of a minimum of 1000 colonies showed uniform colony morphology; and (iii) all of our farnesol
responders were reversible; they returned to the altered colony morphology when farnesol was removed. Thus, although some of our mutants might have resulted from a colony-type switch, that switch must
be exceptionally stable.
Here we have shown that farnesol-responsive mutants are common.
Candida albicans is normally able to respond to 1–2 μmol/L farnesol. These farnesol-responsive mutants may require exogenous farnesol either because their response to farnesol is attenuated such that
they do not respond to the concentrations of farnesol normally encountered in colonies or because high concentrations of farnesol hyperactivates a second, dominant mechanism that inhibits filamentation by overriding the morphogenesis defect of the mutants. Another
example in which farnesol exhibited an overriding control on cellular physiology is provided by Granshaw et al. (2003). In Neurospora
crassa, circadian rhythms can be seen as a series of bands or conidiation regions on the surface of agar media. Mutations in 3 different
genes (frq, wc-1, and wc-2) led to loss of circadian rhythm. However,
addition of farnesol or geraniol (10–100 μmol/L) restored rhythmic
banding to strains lacking a circadian rhythm owing to mutations in
any 1 of these 3 genes. Granshaw et al. (2003) interpreted their data
in terms of a two-oscillator model in which farnesol activated or amplified the remaining oscillator.
Mutants that fail to make detectable farnesol could have a defect in
farnesol synthesis or they could hyperactivate a farnesol-degradation
or -conversion pathway. Further analysis will be necessary to distinguish between these possibilities. Farnesol is synthesized from farnesyl pyrophosphate, an intermediate in the highly conserved sterol biosynthetic pathway (Hornby et al. 2003). An in vitro assay has been
developed for farnesol synthesis from farnesyl pyrophosphate (Hornby
et al. 2003) and we are currently using it to purify and identify the
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proteins responsible for farnesol biosynthesis. Mutants that fail to
make farnesol will be useful in complementation studies, i.e., do the
genes identified by the reverse biochemical approach actually complement the mutations? This will be an important confirmation that the
correct gene or genes have been cloned and a test for whether or not
we have identified all of the genes for farnesol biosynthesis.
Mutants that do not respond to farnesol may be lacking a critical
farnesol receptor, a signal transduction pathway activated by farnesol, or have mutations in a morphogenic pathway that overrides the
farnesol response. For instance, some of these mutants could be defective in CHK1 function (Kruppa et al. 2004). Chk1p is a histidine kinase that functions in a two-component signal transduction pathway
and C. albicans strains lacking both copies of CHK1 do not respond to
farnesol (Kruppa et al. 2004). It may be possible to identify the missing proteins in the mutants by comparing the pattern of proteins from
wild-type and mutant C. albicans on two-dimensional gels.
We observed differences in the frequencies of mutants in distinct
morphological categories for A72 versus CAI-4. The majority of A72
mutants (96.3%) were in the hairy category, whereas there were 2
major categories for the CAI-4 mutants (70% were hairy wrinkled and
26.6% were hairy; Table 1). These differences may reflect genetic differences between the strains. For instance, CAI-4 might be heterozygous for a recessive mutation that results in formation of hairy wrinkled colonies, whereas A72 is wild type for both alleles. If so, mutants
with a hairy wrinkled phenotype would be recovered more frequently
from CAI-4. Similarly, differences in the genetic backgrounds of A72
and CAI-4 might explain the apparent dichotomy leading to shaggy
dog colonies in mutants of A72 and mountain-like colonies in mutants
of CAI-4. Alternatively, this colony difference could be a further manifestation of the iro-1 defect in CAI-4 (Garcia et al. 2001).
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